-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Downgrades Prime Medicine to Neutral

Benzinga·05/20/2025 11:23:29
Listen to the news
JP Morgan analyst Eric Joseph downgrades Prime Medicine (NASDAQ:PRME) from Overweight to Neutral.